Aandelen in “Productie van analytische laboratoriuminstrumenten”

Aandeel Datum Koers Evolutie
vlag Illumina Inc 11/09 206,450 USD
+2,57% 		+2,57%
vlag Integra Lifesciences Holdings Corp 11/09 15,500 USD
-0,26% 		-0,26%

Nieuws over “Productie van analytische laboratoriuminstrumenten”

11/09 · Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference · Persbericht

11/09 · Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference · Persbericht

6/09 · AI-favoriet Bloom Energy en genomicapionier Illumina komen in S&P500 · Tijd.be (€)

De nieuwe, toekomstige leden van de S&P500 gaan een sterke beurssessie tegemoet. Zo'n 20.000 miljard dollar is op de of andere manier gekoppeld aan de beursbarometer.

26/08 · EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & Korsinsky · Persbericht

26/08 · Waters Corporation to Present at the Wells Fargo Healthcare Conference · Persbericht

20/08 · EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals · Persbericht

13/08 · Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program · Persbericht

5/08 · Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 · Persbericht

4/08 · Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results · Persbericht

30/07 · Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 · Persbericht

29/07 · Avantor® Reports Second Quarter 2026 Results · Persbericht

27/07 · Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer · Persbericht

16/07 · Illumina expands Billion Cell Atlas program with new AI drug developers · Persbericht

14/07 · Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product · Persbericht

13/07 · Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier® · Persbericht

9/07 · Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 · Persbericht

9/07 · Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer · Persbericht

6/07 · Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules · Persbericht

2/07 · Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call · Persbericht

1/07 · Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026 · Persbericht

26/06 · Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier® · Persbericht

Mijn selecties